104 related articles for article (PubMed ID: 38943587)
1. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].
Wang GH; Wang CM; Wu XJ; Chu T; Huang DW; Li J
Mol Biol (Mosk); 2024; 58(1):157-159. PubMed ID: 38943587
[TBL] [Abstract][Full Text] [Related]
2. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
3. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.
Yang ZX; Fu YW; Zhao JJ; Zhang F; Li SA; Zhao M; Wen W; Zhang L; Cheng T; Zhang JP; Zhang XB
Genomics Proteomics Bioinformatics; 2023 Dec; 21(6):1206-1220. PubMed ID: 36549468
[TBL] [Abstract][Full Text] [Related]
4. A highly specific SpCas9 variant is identified by in vivo screening in yeast.
Casini A; Olivieri M; Petris G; Montagna C; Reginato G; Maule G; Lorenzin F; Prandi D; Romanel A; Demichelis F; Inga A; Cereseto A
Nat Biotechnol; 2018 Mar; 36(3):265-271. PubMed ID: 29431739
[TBL] [Abstract][Full Text] [Related]
5. Deleting specific residues from the HNH linkers creates a CRISPR-SpCas9 variant with high fidelity and efficiency.
Wang G; Wang C; Chu T; Wu X; Anderson CM; Huang D; Li J
J Biotechnol; 2023 May; 368():42-52. PubMed ID: 37116617
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
7. Shortening the sgRNA-DNA interface enables SpCas9 and eSpCas9(1.1) to nick the target DNA strand.
Fan R; Chai Z; Xing S; Chen K; Qiu F; Chai T; Qiu JL; Zhang Z; Zhang H; Gao C
Sci China Life Sci; 2020 Nov; 63(11):1619-1630. PubMed ID: 32592086
[TBL] [Abstract][Full Text] [Related]
8. Continuous evolution of SpCas9 variants compatible with non-G PAMs.
Miller SM; Wang T; Randolph PB; Arbab M; Shen MW; Huang TP; Matuszek Z; Newby GA; Rees HA; Liu DR
Nat Biotechnol; 2020 Apr; 38(4):471-481. PubMed ID: 32042170
[TBL] [Abstract][Full Text] [Related]
9. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.
Yang Y; Li D; Wan F; Chen B; Wu G; Li F; Ren Y; Liang P; Wan J; Songyang Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429003
[TBL] [Abstract][Full Text] [Related]
10. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into a high fidelity variant of SpCas9.
Guo M; Ren K; Zhu Y; Tang Z; Wang Y; Zhang B; Huang Z
Cell Res; 2019 Mar; 29(3):183-192. PubMed ID: 30664728
[TBL] [Abstract][Full Text] [Related]
12. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9.
Choi GCG; Zhou P; Yuen CTL; Chan BKC; Xu F; Bao S; Chu HY; Thean D; Tan K; Wong KH; Zheng Z; Wong ASL
Nat Methods; 2019 Aug; 16(8):722-730. PubMed ID: 31308554
[TBL] [Abstract][Full Text] [Related]
14. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
[TBL] [Abstract][Full Text] [Related]
15. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
Chen JS; Dagdas YS; Kleinstiver BP; Welch MM; Sousa AA; Harrington LB; Sternberg SH; Joung JK; Yildiz A; Doudna JA
Nature; 2017 Oct; 550(7676):407-410. PubMed ID: 28931002
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition.
Kang M; Zuo Z; Yin Z; Gu J
J Chem Inf Model; 2022 Jun; 62(12):3057-3066. PubMed ID: 35666156
[TBL] [Abstract][Full Text] [Related]
17. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
Goldberg GW; Spencer JM; Giganti DO; Camellato BR; Agmon N; Ichikawa DM; Boeke JD; Noyes MB
Nat Commun; 2021 Jan; 12(1):349. PubMed ID: 33441553
[TBL] [Abstract][Full Text] [Related]
18. PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.
Acharya S; Ansari AH; Kumar Das P; Hirano S; Aich M; Rauthan R; Mahato S; Maddileti S; Sarkar S; Kumar M; Phutela R; Gulati S; Rahman A; Goel A; Afzal C; Paul D; Agrawal T; Pulimamidi VK; Jalali S; Nishimasu H; Mariappan I; Nureki O; Maiti S; Chakraborty D
Nat Commun; 2024 Jun; 15(1):5471. PubMed ID: 38942756
[TBL] [Abstract][Full Text] [Related]
19. Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR-Cas9 variants.
Murugan K; Suresh SK; Seetharam AS; Severin AJ; Sashital DG
Nucleic Acids Res; 2021 Apr; 49(7):4037-4053. PubMed ID: 33744974
[TBL] [Abstract][Full Text] [Related]
20. Target-Specific Precision of CRISPR-Mediated Genome Editing.
Chakrabarti AM; Henser-Brownhill T; Monserrat J; Poetsch AR; Luscombe NM; Scaffidi P
Mol Cell; 2019 Feb; 73(4):699-713.e6. PubMed ID: 30554945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
